Naproxen (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Naproxen" in English language version.

Last modified: 04:11:29, 22 June 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

6043nih.gov

5^th place

3728doi.org

2^nd place

255drugs.com

529^th place

550^th place

116semanticscholar.org

15^th place

8^th place

76web.archive.org

1^st place

66adsabs.harvard.edu

14^th place

9^th place

42fda.gov

470^th place

329^th place

33hdl.handle.net

66^th place

34^th place

32nhs.uk

2,637^th place

2,254^th place

22books.google.com

3^rd place

22clincalc.com

5,833^rd place

4,432^nd place

11comlaw.gov.au

low place

11medicines.org.uk

4,892^nd place

3,451^st place

11archive.org

6^th place

11wiley.com

150^th place

174^th place

11ssrn.com

907^th place

529^th place

11hpra.ie

low place

11mhra.gov.uk

low place

11ctchealth.ca

low place

11bayer.ca

low place

11newswire.ca

3,066^th place

1,749^th place

11opq.org

low place

11eurekalert.org

3,950^th place

3,383^rd place

11worldcat.org

4^th place

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (May 2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proceedings of the National Academy of Sciences of the United States of America. 108 (22): 9262–9267. Bibcode:2011PNAS..108.9262W. doi:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Moreno Ríos AL, Gutierrez-Suarez K, Carmona Z, Ramos CG, Silva Oliveira LF (March 2022). "Pharmaceuticals as emerging pollutants: Case naproxen an overview". Chemosphere. 291 (Pt 1) 132822. Bibcode:2022Chmsp.29132822M. doi:10.1016/j.chemosphere.2021.132822. hdl:11323/9007. PMID 34767851.
Mulkiewicz E, Wolecki D, Świacka K, Kumirska J, Stepnowski P, Caban M (October 2021). "Metabolism of non-steroidal anti-inflammatory drugs by non-target wild-living organisms". The Science of the Total Environment. 791 148251. Bibcode:2021ScTEn.79148251M. doi:10.1016/j.scitotenv.2021.148251. PMID 34139498.
Huynh NC, Nguyen TT, Nguyen DT, Tran TV (November 2023). "Occurrence, toxicity, impact and removal of selected non-steroidal anti-inflammatory drugs (NSAIDs): A review". The Science of the Total Environment. 898 165317. Bibcode:2023ScTEn.89865317H. doi:10.1016/j.scitotenv.2023.165317. PMID 37419350.
Parolini M (October 2020). "Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review". The Science of the Total Environment. 740 140043. Bibcode:2020ScTEn.74040043P. doi:10.1016/j.scitotenv.2020.140043. hdl:2434/747078. PMID 32559537.
Mojiri A, Zhou JL, Ratnaweera H, Rezania S, Nazari VM (February 2022). "Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems". Chemosphere. 288 (Pt 2) 132580. Bibcode:2022Chmsp.28832580M. doi:10.1016/j.chemosphere.2021.132580. PMID 34687686.

archive.org (Global: 6^th place; English: 6^th place)

Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. pp. 665, 673. ISBN 978-0-85711-084-8.

bayer.ca (Global: low place; English: low place)

"Aleve – Welcome to Canada, Eh!" (PDF) (Press release). Bayer Health Care. 14 July 2009. Retrieved 24 March 2012.

books.google.com (Global: 3^rd place; English: 3^rd place)

McEvoy GK (2000). AHFS Drug Information, 2000. American Society of Health-System Pharmacists. p. 1854. ISBN 978-1-58528-004-9.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 520. ISBN 978-3-527-60749-5.

clincalc.com (Global: 5,833^rd place; English: 4,432^nd place)

"Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
"Naproxen Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 18 August 2025.

comlaw.gov.au (Global: low place; English: low place)

Gill A, ed. (July 2013). Standard for the Uniform Scheduling of Medicines and Poisons No. 4 (PDF). Therapeutic Goods Administration. ISBN 978-1-74241-895-7.

ctchealth.ca (Global: low place; English: low place)

"Aleve products released in Canada".

doi.org (Global: 2^nd place; English: 2^nd place)

Angiolillo DJ, Weisman SM (April 2017). "Clinical Pharmacology and Cardiovascular Safety of Naproxen". American Journal of Cardiovascular Drugs. 17 (2): 97–107. doi:10.1007/s40256-016-0200-5. PMC 5340840. PMID 27826802.
Derry C, Derry S, Moore RA, McQuay HJ (January 2009). "Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults". The Cochrane Database of Systematic Reviews. 2009 (1) CD004234. doi:10.1002/14651858.CD004234.pub3. PMC 6483469. PMID 19160232.
Garza I, Schwedt TJ (April 2010). "Diagnosis and management of chronic daily headache". Seminars in Neurology. 30 (2). WebMD LLC: 154–166. doi:10.1055/s-0030-1249224. PMID 20352585.
Perneger TV, Whelton PK, Klag MJ (December 1994). "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs". The New England Journal of Medicine. 331 (25): 1675–1679. doi:10.1056/nejm199412223312502. PMID 7969358.
Richy F, Bruyere O, Ethgen O, Rabenda V, Bouvenot G, Audran M, et al. (July 2004). "Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–766. doi:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, et al. (December 2016). "Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis". The New England Journal of Medicine. 375 (26): 2519–2529. doi:10.1056/NEJMoa1611593. PMID 27959716.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. (January 2011). "Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis". BMJ. 342 c7086. doi:10.1136/bmj.c7086. PMC 3019238. PMID 21224324. c7086.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al. (August 2013). "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials". Lancet. 382 (9894): 769–779. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (May 2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proceedings of the National Academy of Sciences of the United States of America. 108 (22): 9262–9267. Bibcode:2011PNAS..108.9262W. doi:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Turner MS, May DB, Arthur RR, Xiong GL (March 2007). "Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks". Journal of Internal Medicine. 261 (3): 205–213. doi:10.1111/j.1365-2796.2006.01720.x. PMID 17305643. S2CID 41772614.
Pfau PR, Lichenstein GR (November 1999). "NSAIDs and alcohol: never the twain shall mix?". The American Journal of Gastroenterology. 94 (11): 3098–3101. doi:10.1111/j.1572-0241.1999.03098.x. PMID 10566697. S2CID 41310743.
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, et al. (November 2010). "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen". The Journal of Biological Chemistry. 285 (45): 34950–34959. doi:10.1074/jbc.M110.162982. PMC 2966109. PMID 20810665.
Hinz B, Cheremina O, Besz D, Zlotnick S, Brune K (April 2008). "Impact of naproxen sodium at over-the-counter doses on cyclooxygenase isoforms in human volunteers". International Journal of Clinical Pharmacology and Therapeutics. 46 (4): 180–186. doi:10.5414/CPP46180. PMID 18397691.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, et al. (October 2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". Journal of Clinical Pharmacology. 40 (10): 1109–1120. doi:10.1177/009127000004001005. PMID 11028250. S2CID 24736336. Archived from the original on 23 February 2020. Retrieved 23 February 2020.
Gross GJ, Moore J (July 2004). "Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine". Pharmacology. 71 (3): 135–142. doi:10.1159/000077447. PMID 15161995. S2CID 34018223.
Hawkey CJ (October 2001). "COX-1 and COX-2 inhibitors". Best Practice & Research. Clinical Gastroenterology. 15 (5): 801–820. doi:10.1053/bega.2001.0236. PMID 11566042.
Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen CP, Vree JB, Guelen PJ (August 1993). "Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans". Biopharmaceutics & Drug Disposition. 14 (6): 491–502. doi:10.1002/bdd.2510140605. PMID 8218967. S2CID 35920001.
Rodrigues AD (November 2005). "Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?". Drug Metabolism and Disposition. 33 (11): 1567–1575. doi:10.1124/dmd.105.006452. PMID 16118328. S2CID 5754183.
el Mouelhi M, Ruelius HW, Fenselau C, Dulik DM (1987). "Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen". Drug Metabolism and Disposition. 15 (6): 767–772. doi:10.1016/S0090-9556(25)06837-0. PMID 2893700.
Harrington PJ, Lodewijk E (1997). "Twenty Years of Naproxen Technology". Org. Process Res. Dev. 1 (1): 72–76. doi:10.1021/op960009e.
Wojcieszyńska D, Guzik U (March 2020). "Naproxen in the environment: its occurrence, toxicity to nontarget organisms and biodegradation". Applied Microbiology and Biotechnology. 104 (5): 1849–1857. doi:10.1007/s00253-019-10343-x. PMC 7007908. PMID 31925484.
Rodríguez-Serin H, Gamez-Jara A, De La Cruz-Noriega M, Rojas-Flores S, Rodriguez-Yupanqui M, Gallozzo Cardenas M, et al. (October 2022). "Literature Review: Evaluation of Drug Removal Techniques in Municipal and Hospital Wastewater". International Journal of Environmental Research and Public Health. 19 (20) 13105. doi:10.3390/ijerph192013105. PMC 9602914. PMID 36293682.
Moreno Ríos AL, Gutierrez-Suarez K, Carmona Z, Ramos CG, Silva Oliveira LF (March 2022). "Pharmaceuticals as emerging pollutants: Case naproxen an overview". Chemosphere. 291 (Pt 1) 132822. Bibcode:2022Chmsp.29132822M. doi:10.1016/j.chemosphere.2021.132822. hdl:11323/9007. PMID 34767851.
Mulkiewicz E, Wolecki D, Świacka K, Kumirska J, Stepnowski P, Caban M (October 2021). "Metabolism of non-steroidal anti-inflammatory drugs by non-target wild-living organisms". The Science of the Total Environment. 791 148251. Bibcode:2021ScTEn.79148251M. doi:10.1016/j.scitotenv.2021.148251. PMID 34139498.
Huynh NC, Nguyen TT, Nguyen DT, Tran TV (November 2023). "Occurrence, toxicity, impact and removal of selected non-steroidal anti-inflammatory drugs (NSAIDs): A review". The Science of the Total Environment. 898 165317. Bibcode:2023ScTEn.89865317H. doi:10.1016/j.scitotenv.2023.165317. PMID 37419350.
Parolini M (October 2020). "Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review". The Science of the Total Environment. 740 140043. Bibcode:2020ScTEn.74040043P. doi:10.1016/j.scitotenv.2020.140043. hdl:2434/747078. PMID 32559537.
Mojiri A, Zhou JL, Ratnaweera H, Rezania S, Nazari VM (February 2022). "Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems". Chemosphere. 288 (Pt 2) 132580. Bibcode:2022Chmsp.28832580M. doi:10.1016/j.chemosphere.2021.132580. PMID 34687686.
Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. (May 2013). "Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus". Antimicrobial Agents and Chemotherapy. 57 (5): 2231–2242. doi:10.1128/AAC.02335-12. PMC 3632891. PMID 23459490.
Lay summary at: "Pain reliever shows anti-viral activity against flu". EurekAlert!.

drugs.com (Global: 529^th place; English: 550^th place)

"Naproxen". Drugs.com. 2017. Retrieved 7 February 2017.
"Naproxen international". Drugs.com. 7 December 2020. Retrieved 3 January 2021.
"Naproxen Use During Pregnancy". Drugs.com. 13 August 2019. Retrieved 27 December 2019.
"Naproxen Monograph for Professionals". Drugs.com. AHFS. Retrieved 19 December 2018.
"L490 (Naproxen 220 mg)". drugs.com. Retrieved 17 May 2017.

eurekalert.org (Global: 3,950^th place; English: 3,383^rd place)

Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. (May 2013). "Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus". Antimicrobial Agents and Chemotherapy. 57 (5): 2231–2242. doi:10.1128/AAC.02335-12. PMC 3632891. PMID 23459490.
Lay summary at: "Pain reliever shows anti-viral activity against flu". EurekAlert!.

fda.gov (Global: 470^th place; English: 329^th place)

"FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications". U.S. Food and Drug Administration (FDA) (Press release). 15 October 2020. Retrieved 15 October 2020.^{[dead link]} This article incorporates text from this source, which is in the public domain.
"NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 July 2017. Archived from the original on 17 October 2020. Retrieved 15 October 2020. This article incorporates text from this source, which is in the public domain.

hdl.handle.net (Global: 66^th place; English: 34^th place)

World Health Organization (2025). The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list. Geneva: World Health Organization. hdl:10665/382243.
Moreno Ríos AL, Gutierrez-Suarez K, Carmona Z, Ramos CG, Silva Oliveira LF (March 2022). "Pharmaceuticals as emerging pollutants: Case naproxen an overview". Chemosphere. 291 (Pt 1) 132822. Bibcode:2022Chmsp.29132822M. doi:10.1016/j.chemosphere.2021.132822. hdl:11323/9007. PMID 34767851.
Parolini M (October 2020). "Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review". The Science of the Total Environment. 740 140043. Bibcode:2020ScTEn.74040043P. doi:10.1016/j.scitotenv.2020.140043. hdl:2434/747078. PMID 32559537.

hpra.ie (Global: low place; English: low place)

assets.hpra.ie

"Package Leaflet: information for the user | MOMENDOL, 220 mg film-coated tablets | Naproxen sodium" (PDF). hpra.ie.

medicines.org.uk (Global: 4,892^nd place; English: 3,451^st place)

"Boots Period Pain Relief 250 mg Gastro-Resistant Tablets - Summary of Product Characteristics (SmPC)". (emc). 4 February 2013. Retrieved 12 February 2023.

mhra.gov.uk (Global: low place; English: low place)

"Medicines regulator approves availability of a new OTC medicine for period pain" (Press release). Medicines and Healthcare products Regulatory Agency (MHRA). 1 April 2008. Archived from the original (PDF) on 21 September 2013.

newswire.ca (Global: 3,066^th place; English: 1,749^th place)

"Aleve – Helping British Columbians with Joint and Arthritis Pain Get Back to Doing the Activities They Love". newswire.ca. 28 January 2010. Archived from the original on 21 September 2013. Retrieved 27 September 2012.

nhs.uk (Global: 2,637^th place; English: 2,254^th place)

"Medicines A to Z - Naproxen". NHS. National Health Service. 24 October 2018. Retrieved 11 March 2020.
"How to take it". NHS.Gov. 20 January 2022.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Angiolillo DJ, Weisman SM (April 2017). "Clinical Pharmacology and Cardiovascular Safety of Naproxen". American Journal of Cardiovascular Drugs. 17 (2): 97–107. doi:10.1007/s40256-016-0200-5. PMC 5340840. PMID 27826802.
Derry C, Derry S, Moore RA, McQuay HJ (January 2009). "Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults". The Cochrane Database of Systematic Reviews. 2009 (1) CD004234. doi:10.1002/14651858.CD004234.pub3. PMC 6483469. PMID 19160232.
Garza I, Schwedt TJ (April 2010). "Diagnosis and management of chronic daily headache". Seminars in Neurology. 30 (2). WebMD LLC: 154–166. doi:10.1055/s-0030-1249224. PMID 20352585.
Perneger TV, Whelton PK, Klag MJ (December 1994). "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs". The New England Journal of Medicine. 331 (25): 1675–1679. doi:10.1056/nejm199412223312502. PMID 7969358.
Allen RE, Kirby KA (August 2012). "Nocturnal leg cramps". American Family Physician. 86 (4): 350–355. PMID 22963024.
Richy F, Bruyere O, Ethgen O, Rabenda V, Bouvenot G, Audran M, et al. (July 2004). "Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–766. doi:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, et al. (December 2016). "Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis". The New England Journal of Medicine. 375 (26): 2519–2529. doi:10.1056/NEJMoa1611593. PMID 27959716.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. (January 2011). "Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis". BMJ. 342 c7086. doi:10.1136/bmj.c7086. PMC 3019238. PMID 21224324. c7086.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al. (August 2013). "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials". Lancet. 382 (9894): 769–779. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (May 2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proceedings of the National Academy of Sciences of the United States of America. 108 (22): 9262–9267. Bibcode:2011PNAS..108.9262W. doi:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Turner MS, May DB, Arthur RR, Xiong GL (March 2007). "Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks". Journal of Internal Medicine. 261 (3): 205–213. doi:10.1111/j.1365-2796.2006.01720.x. PMID 17305643. S2CID 41772614.
Pfau PR, Lichenstein GR (November 1999). "NSAIDs and alcohol: never the twain shall mix?". The American Journal of Gastroenterology. 94 (11): 3098–3101. doi:10.1111/j.1572-0241.1999.03098.x. PMID 10566697. S2CID 41310743.
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, et al. (November 2010). "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen". The Journal of Biological Chemistry. 285 (45): 34950–34959. doi:10.1074/jbc.M110.162982. PMC 2966109. PMID 20810665.
Hinz B, Cheremina O, Besz D, Zlotnick S, Brune K (April 2008). "Impact of naproxen sodium at over-the-counter doses on cyclooxygenase isoforms in human volunteers". International Journal of Clinical Pharmacology and Therapeutics. 46 (4): 180–186. doi:10.5414/CPP46180. PMID 18397691.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, et al. (October 2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". Journal of Clinical Pharmacology. 40 (10): 1109–1120. doi:10.1177/009127000004001005. PMID 11028250. S2CID 24736336. Archived from the original on 23 February 2020. Retrieved 23 February 2020.
Gross GJ, Moore J (July 2004). "Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine". Pharmacology. 71 (3): 135–142. doi:10.1159/000077447. PMID 15161995. S2CID 34018223.
Hawkey CJ (October 2001). "COX-1 and COX-2 inhibitors". Best Practice & Research. Clinical Gastroenterology. 15 (5): 801–820. doi:10.1053/bega.2001.0236. PMID 11566042.
Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen CP, Vree JB, Guelen PJ (August 1993). "Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans". Biopharmaceutics & Drug Disposition. 14 (6): 491–502. doi:10.1002/bdd.2510140605. PMID 8218967. S2CID 35920001.
Rodrigues AD (November 2005). "Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?". Drug Metabolism and Disposition. 33 (11): 1567–1575. doi:10.1124/dmd.105.006452. PMID 16118328. S2CID 5754183.
el Mouelhi M, Ruelius HW, Fenselau C, Dulik DM (1987). "Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen". Drug Metabolism and Disposition. 15 (6): 767–772. doi:10.1016/S0090-9556(25)06837-0. PMID 2893700.
Wojcieszyńska D, Guzik U (March 2020). "Naproxen in the environment: its occurrence, toxicity to nontarget organisms and biodegradation". Applied Microbiology and Biotechnology. 104 (5): 1849–1857. doi:10.1007/s00253-019-10343-x. PMC 7007908. PMID 31925484.
Rodríguez-Serin H, Gamez-Jara A, De La Cruz-Noriega M, Rojas-Flores S, Rodriguez-Yupanqui M, Gallozzo Cardenas M, et al. (October 2022). "Literature Review: Evaluation of Drug Removal Techniques in Municipal and Hospital Wastewater". International Journal of Environmental Research and Public Health. 19 (20) 13105. doi:10.3390/ijerph192013105. PMC 9602914. PMID 36293682.
Moreno Ríos AL, Gutierrez-Suarez K, Carmona Z, Ramos CG, Silva Oliveira LF (March 2022). "Pharmaceuticals as emerging pollutants: Case naproxen an overview". Chemosphere. 291 (Pt 1) 132822. Bibcode:2022Chmsp.29132822M. doi:10.1016/j.chemosphere.2021.132822. hdl:11323/9007. PMID 34767851.
Mulkiewicz E, Wolecki D, Świacka K, Kumirska J, Stepnowski P, Caban M (October 2021). "Metabolism of non-steroidal anti-inflammatory drugs by non-target wild-living organisms". The Science of the Total Environment. 791 148251. Bibcode:2021ScTEn.79148251M. doi:10.1016/j.scitotenv.2021.148251. PMID 34139498.
Huynh NC, Nguyen TT, Nguyen DT, Tran TV (November 2023). "Occurrence, toxicity, impact and removal of selected non-steroidal anti-inflammatory drugs (NSAIDs): A review". The Science of the Total Environment. 898 165317. Bibcode:2023ScTEn.89865317H. doi:10.1016/j.scitotenv.2023.165317. PMID 37419350.
Parolini M (October 2020). "Toxicity of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: A review". The Science of the Total Environment. 740 140043. Bibcode:2020ScTEn.74040043P. doi:10.1016/j.scitotenv.2020.140043. hdl:2434/747078. PMID 32559537.
Mojiri A, Zhou JL, Ratnaweera H, Rezania S, Nazari VM (February 2022). "Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems". Chemosphere. 288 (Pt 2) 132580. Bibcode:2022Chmsp.28832580M. doi:10.1016/j.chemosphere.2021.132580. PMID 34687686.
Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. (May 2013). "Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus". Antimicrobial Agents and Chemotherapy. 57 (5): 2231–2242. doi:10.1128/AAC.02335-12. PMC 3632891. PMID 23459490.
Lay summary at: "Pain reliever shows anti-viral activity against flu". EurekAlert!.

ncbi.nlm.nih.gov

Angiolillo DJ, Weisman SM (April 2017). "Clinical Pharmacology and Cardiovascular Safety of Naproxen". American Journal of Cardiovascular Drugs. 17 (2): 97–107. doi:10.1007/s40256-016-0200-5. PMC 5340840. PMID 27826802.
Derry C, Derry S, Moore RA, McQuay HJ (January 2009). "Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults". The Cochrane Database of Systematic Reviews. 2009 (1) CD004234. doi:10.1002/14651858.CD004234.pub3. PMC 6483469. PMID 19160232.
"Naproxen". PubMed Health. 1 September 2008. Archived from the original on 22 July 2010.
Richy F, Bruyere O, Ethgen O, Rabenda V, Bouvenot G, Audran M, et al. (July 2004). "Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach". Annals of the Rheumatic Diseases. 63 (7): 759–766. doi:10.1136/ard.2003.015925. PMC 1755051. PMID 15194568.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. (January 2011). "Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis". BMJ. 342 c7086. doi:10.1136/bmj.c7086. PMC 3019238. PMID 21224324. c7086.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al. (August 2013). "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials". Lancet. 382 (9894): 769–779. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P (May 2011). "Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans". Proceedings of the National Academy of Sciences of the United States of America. 108 (22): 9262–9267. Bibcode:2011PNAS..108.9262W. doi:10.1073/pnas.1104836108. PMC 3107316. PMID 21518864.
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, et al. (November 2010). "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen". The Journal of Biological Chemistry. 285 (45): 34950–34959. doi:10.1074/jbc.M110.162982. PMC 2966109. PMID 20810665.
Wojcieszyńska D, Guzik U (March 2020). "Naproxen in the environment: its occurrence, toxicity to nontarget organisms and biodegradation". Applied Microbiology and Biotechnology. 104 (5): 1849–1857. doi:10.1007/s00253-019-10343-x. PMC 7007908. PMID 31925484.
Rodríguez-Serin H, Gamez-Jara A, De La Cruz-Noriega M, Rojas-Flores S, Rodriguez-Yupanqui M, Gallozzo Cardenas M, et al. (October 2022). "Literature Review: Evaluation of Drug Removal Techniques in Municipal and Hospital Wastewater". International Journal of Environmental Research and Public Health. 19 (20) 13105. doi:10.3390/ijerph192013105. PMC 9602914. PMID 36293682.
Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. (May 2013). "Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus". Antimicrobial Agents and Chemotherapy. 57 (5): 2231–2242. doi:10.1128/AAC.02335-12. PMC 3632891. PMID 23459490.
Lay summary at: "Pain reliever shows anti-viral activity against flu". EurekAlert!.

dailymed.nlm.nih.gov

"Naprosyn- naproxen tablet EC-Naprosyn- naproxen tablet, delayed release Anaprox DS- naproxen sodium tablet". DailyMed. 1 July 2019. Retrieved 27 December 2019.
"Vimovo- naproxen and esomeprazole magnesium tablet, delayed release". DailyMed. 2 August 2019. Retrieved 27 December 2019.
"Aleve- naproxen sodium tablet". DailyMed. 4 November 2019. Retrieved 27 December 2019.

nlm.nih.gov

"LACTMED: NAPROXEN". TOXNET. NIH. Retrieved 21 July 2017.

opq.org (Global: low place; English: low place)

"Modifications aux annexes de médicaments". Ordre des pharmaciens du Québec (in Canadian French). Retrieved 16 May 2025.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Turner MS, May DB, Arthur RR, Xiong GL (March 2007). "Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks". Journal of Internal Medicine. 261 (3): 205–213. doi:10.1111/j.1365-2796.2006.01720.x. PMID 17305643. S2CID 41772614.
Pfau PR, Lichenstein GR (November 1999). "NSAIDs and alcohol: never the twain shall mix?". The American Journal of Gastroenterology. 94 (11): 3098–3101. doi:10.1111/j.1572-0241.1999.03098.x. PMID 10566697. S2CID 41310743.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, et al. (October 2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". Journal of Clinical Pharmacology. 40 (10): 1109–1120. doi:10.1177/009127000004001005. PMID 11028250. S2CID 24736336. Archived from the original on 23 February 2020. Retrieved 23 February 2020.
Gross GJ, Moore J (July 2004). "Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine". Pharmacology. 71 (3): 135–142. doi:10.1159/000077447. PMID 15161995. S2CID 34018223.
Vree TB, van den Biggelaar-Martea M, Verwey-van Wissen CP, Vree JB, Guelen PJ (August 1993). "Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans". Biopharmaceutics & Drug Disposition. 14 (6): 491–502. doi:10.1002/bdd.2510140605. PMID 8218967. S2CID 35920001.
Rodrigues AD (November 2005). "Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?". Drug Metabolism and Disposition. 33 (11): 1567–1575. doi:10.1124/dmd.105.006452. PMID 16118328. S2CID 5754183.

ssrn.com (Global: 907^th place; English: 529^th place)

papers.ssrn.com

Parry ME, Katie F. "The Aleve Launch (A)". SSRN 1420558.

web.archive.org (Global: 1^st place; English: 1^st place)

"Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
"NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 July 2017. Archived from the original on 17 October 2020. Retrieved 15 October 2020. This article incorporates text from this source, which is in the public domain.
"Naproxen". PubMed Health. 1 September 2008. Archived from the original on 22 July 2010.
Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, et al. (October 2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". Journal of Clinical Pharmacology. 40 (10): 1109–1120. doi:10.1177/009127000004001005. PMID 11028250. S2CID 24736336. Archived from the original on 23 February 2020. Retrieved 23 February 2020.
"Medicines regulator approves availability of a new OTC medicine for period pain" (Press release). Medicines and Healthcare products Regulatory Agency (MHRA). 1 April 2008. Archived from the original (PDF) on 21 September 2013.
"Aleve – Helping British Columbians with Joint and Arthritis Pain Get Back to Doing the Activities They Love". newswire.ca. 28 January 2010. Archived from the original on 21 September 2013. Retrieved 27 September 2012.

wiley.com (Global: 150^th place; English: 174^th place)

accp1.onlinelibrary.wiley.com

Van Hecken A, Schwartz JI, Depré M, De Lepeleire I, Dallob A, Tanaka W, et al. (October 2000). "Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers". Journal of Clinical Pharmacology. 40 (10): 1109–1120. doi:10.1177/009127000004001005. PMID 11028250. S2CID 24736336. Archived from the original on 23 February 2020. Retrieved 23 February 2020.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

McIlwraith CW, Frisbie DD, Kawcak CE (2001). "Nonsteroidal Anti-Inflammatory Drugs". Proceedings of the Annual Convention of the American Association of Equine Practitioners. 47: 182–187. ISSN 0065-7182.

Naproxen (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

archive.org (Global: 6th place; English: 6th place)

bayer.ca (Global: low place; English: low place)

books.google.com (Global: 3rd place; English: 3rd place)

clincalc.com (Global: 5,833rd place; English: 4,432nd place)

comlaw.gov.au (Global: low place; English: low place)

ctchealth.ca (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

drugs.com (Global: 529th place; English: 550th place)

eurekalert.org (Global: 3,950th place; English: 3,383rd place)

fda.gov (Global: 470th place; English: 329th place)

hdl.handle.net (Global: 66th place; English: 34th place)

hpra.ie (Global: low place; English: low place)

assets.hpra.ie

medicines.org.uk (Global: 4,892nd place; English: 3,451st place)

mhra.gov.uk (Global: low place; English: low place)

newswire.ca (Global: 3,066th place; English: 1,749th place)

nhs.uk (Global: 2,637th place; English: 2,254th place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

nlm.nih.gov

opq.org (Global: low place; English: low place)

semanticscholar.org (Global: 15th place; English: 8th place)

api.semanticscholar.org

ssrn.com (Global: 907th place; English: 529th place)

papers.ssrn.com

web.archive.org (Global: 1st place; English: 1st place)

wiley.com (Global: 150th place; English: 174th place)

accp1.onlinelibrary.wiley.com

worldcat.org (Global: 4th place; English: 4th place)

search.worldcat.org

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

archive.org (Global: 6^th place; English: 6^th place)

books.google.com (Global: 3^rd place; English: 3^rd place)

clincalc.com (Global: 5,833^rd place; English: 4,432^nd place)

doi.org (Global: 2^nd place; English: 2^nd place)

drugs.com (Global: 529^th place; English: 550^th place)

eurekalert.org (Global: 3,950^th place; English: 3,383^rd place)

fda.gov (Global: 470^th place; English: 329^th place)

hdl.handle.net (Global: 66^th place; English: 34^th place)

medicines.org.uk (Global: 4,892^nd place; English: 3,451^st place)

newswire.ca (Global: 3,066^th place; English: 1,749^th place)

nhs.uk (Global: 2,637^th place; English: 2,254^th place)

nih.gov (Global: 5^th place; English: 5^th place)

semanticscholar.org (Global: 15^th place; English: 8^th place)

ssrn.com (Global: 907^th place; English: 529^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

wiley.com (Global: 150^th place; English: 174^th place)

worldcat.org (Global: 4^th place; English: 4^th place)